In agreement with these findings, biological evidence suggests that the inactivation of STAT3 and STAT6 transcriptional factors are associated with reducing tumor growth and metastasis in a model of breast and lung cancer (31, 34). The gene discussed is STAT3; the disease is lung carcinoma.